Clinical trial
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's…
NCT00006102 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006102 |
|---|---|
| Title | Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma |
| Official title | A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | becatecarin |
| Enrollment | 200 |
| Start date | Jul 1, 2000 |
| Primary completion | Jun 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 5, 2013 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: